$35.8M for Miramar Labs
Sunnyvale, CA-based Miramar Labs, which has developed a laser-based device for treating “axillary hyperhidrosis” (excessive sweating), has raised $35.8 million in Series C financing, according to a report today from Dow Jones VentureWire. New investors Aisling Capital and Cross Creek Capital led the round, which was joined by existing investors Domain Associates and Morgenthaler Ventures. The company plans to use the funds to begin marketing the device—which the FDA approved earlier this year—to dermatologists.
Trending on Xconomy
By posting a comment, you agree to our terms and conditions.